GIBSON LANE PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: B86036 | LEEDS, LS25 7JN
Showing results 51-100 of 669
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Dapagliflozin | 994 | 29.3K | £36.3K | -20.6% ▼ |
| Fexofenadine hydrochloride | 953 | 51.7K | £2.3K | +12.1% ▲ |
| Fluticasone furoate/vilanterol | 951 | 1,131 | £25.0K | +514.3% ▲ |
| Warfarin sodium | 922 | 38.1K | £1.4K | +95.5% ▲ |
| Rosuvastatin calcium | 920 | 38.5K | £1.9K | +2.5% ▲ |
| Venlafaxine | 917 | 39.4K | £9.2K | +8.5% ▲ |
| Spironolactone | 914 | 28.0K | £3.2K | +69.5% ▲ |
| Ezetimibe | 908 | 35.6K | £6.3K | +27.6% ▲ |
| Naproxen | 905 | 55.7K | £2.4K | -8.3% ▼ |
| Bendroflumethiazide | 888 | 42.7K | £684 | +14.8% ▲ |
| Ferrous sulfate | 838 | 36.9K | £1.2K | +63.0% ▲ |
| Tramadol hydrochloride | 820 | 93.5K | £3.8K | +14.4% ▲ |
| Fluticasone/umeclidinium/vilanterol | 801 | 872 | £36.8K | +241.7% ▲ |
| Empagliflozin | 798 | 29.1K | £36.1K | +27.5% ▲ |
| Sildenafil (Erectile Dysfunction) | 763 | 7,382 | £1.0K | +51.4% ▲ |
| Desogestrel | 753 | 109.6K | £3.3K | +90.0% ▲ |
| Rivaroxaban | 747 | 26.2K | £18.0K | +22.1% ▲ |
| Other emollient preparations | 721 | 422.8K | £5.6K | +20.0% ▲ |
| Senna | 718 | 51.1K | £1.1K | +19.3% ▲ |
| Cetirizine hydrochloride | 718 | 43.6K | £1.7K | +43.7% ▲ |
| Levetiracetam | 717 | 58.4K | £9.9K | +56.6% ▲ |
| Atenolol | 710 | 32.9K | £750 | +17.8% ▲ |
| Latanoprost | 710 | 9,988 | £3.7K | +46.3% ▲ |
| 704 | 1,519 | £53.5K | +29.2% ▲ | |
| Budesonide | 677 | 1,101 | £14.9K | +24.9% ▲ |
| Alendronic acid | 676 | 3,560 | £1.0K | -9.9% ▼ |
| Glucose blood testing reagents | 674 | 73.7K | £11.7K | -14.6% ▼ |
| Hydrocortisone | 673 | 18.6K | £2.8K | +50.1% ▲ |
| Umeclidinium bromide/vilanterol | 672 | 788 | £24.2K | +244.6% ▲ |
| Carbocisteine | 664 | 106.4K | £3.6K | +24.4% ▲ |
| Nitrofurantoin | 664 | 8,744 | £4.5K | +39.2% ▲ |
| Isosorbide mononitrate | 658 | 33.1K | £4.1K | -0.4% vs avg |
| Solifenacin | 655 | 26.8K | £1.1K | +37.3% ▲ |
| Hydroxocobalamin | 649 | 815 | £1.7K | +34.9% ▲ |
| Buprenorphine | 641 | 3,121 | £13.9K | +75.0% ▲ |
| Flucloxacillin sodium | 627 | 28.7K | £1.6K | +39.4% ▲ |
| Lamotrigine | 615 | 47.4K | £6.2K | +4.1% ▲ |
| Gliclazide | 612 | 45.7K | £1.2K | -28.1% ▼ |
| Doxycycline hyclate | 591 | 9,146 | £897 | +15.3% ▲ |
| Diltiazem hydrochloride | 584 | 28.1K | £5.1K | +90.2% ▲ |
| Methotrexate | 584 | 16.0K | £941 | +79.4% ▲ |
| Famotidine | 577 | 30.4K | £16.9K | +18.3% ▲ |
| 546 | 580 | £25.6K | +75.8% ▲ | |
| Estriol | 545 | 8,883 | £4.0K | +156.1% ▲ |
| Canagliflozin | 511 | 21.9K | £27.1K | +255.9% ▲ |
| Lactulose | 499 | 241.7K | £2.3K | +51.6% ▲ |
| Glyceryl trinitrate | 496 | 1,313 | £1.5K | +109.7% ▲ |
| Perindopril erbumine | 487 | 18.8K | £1.6K | -8.3% ▼ |
| Mebeverine hydrochloride | 472 | 41.3K | £5.1K | +52.0% ▲ |
| Mometasone furoate | 465 | 530 | £4.1K | +15.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.